IRCT20181005041243N2尚未招募2 期
Efficacy and safety of minoxidil 5% with or without spironolactone 2% in treating patients with androgenic alopecia
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 years 至 60 years（—）
- 性别
- All
入选标准
- •Aged 18-60
- •Clinical diagnosis of androgenic alopecia with a dermatologist
- •Have not received any drug for alopecia in the past 12 months
排除标准
- •Pregnancy or breastfeeding during the intervention
- •history of internal diseases, including endocrine diseases causing alopecia
- •alteration in diet and lifestyle during the study
- •polycystic ovary syndrome
- •The disease caused by another reason than androgenic alopecia
- •Consuming any systemic or topical drugs which caused hair loss or hair regrowth
- •Have a history of hair transplantation
- •History of skin diseases which cause hair loss like cutaneous cancers, infection, psoriasis
- •photosensitivity
研究者
相似试验
招募中
3 期
Comparison of the Effectiveness of Minoxidil, Cetirizine 1% and Diclofenac 3% in treatment of androgenic alopeciaIRCT20190511043547N1Shahid Beheshti University of medical sciences54
招募中
3 期
Comparison of the therapeutic effects of minoxidil solution alone with the combination of minoxidil and flutamide solution in patients with androgenic alopeciaIRCT20200825048515N6Esfahan University of Medical Sciences40
招募中
4 期
A clinical trial to study the effect of topical minoxidil 5% solution alone and a combination topical minoxidil 5% and finasteride 0.1% solution for the treatment of common baldness in meCTRI/2017/10/010054Government Medical College and Hospital Sector Chandigarh
招募中
3 期
Comparison of the effect of 5% minoxidil and topical epinephrine on the prevention of chemotherapy-induced hair loss in patients with breast cancer compared to the control group (placebo recipients) in 1398-1399Chemotherapy-induced hair loss.IRCT20200205046380N1Shahid Beheshti University of Medical Sciences63
进行中（未招募）
不适用
Comparison of the efficiency between Minoxidil 5% or Finasteride 1mg and Minoxidil 5% + Finasteride 1mg in androgenetic alopecia (male pattern) at Hamilton classification scale II - V. - Comparative Efficiency of Finasteride and MinoxidilAlopecia androgeneticaEUCTR2005-005418-19-DEDr. med. Bernd Salzer, Private Praxis